Cytopathologic and Immunophenotypic Changes in NUT Midline Carcinoma After Targeted Therapy

Cancer cytopathology - United States
doi 10.1002/cncy.21794
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Diagnosis of NUT Midline Carcinoma Using a NUT-specific Monoclonal Antibody

American Journal of Surgical Pathology
AnatomyForensic MedicinePathologySurgery
2009English

Clinicopathologic Features and Long-Term Outcomes of NUT Midline Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2012English

Primary Pulmonary NUT Midline Carcinoma: Clinical, Radiographic, and Pathologic Characterizations

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2015English

O3-7-3Prevalence, Genetic Features, and Anti-Cancer Drug Sensitivity of NUT Midline Carcinoma

Annals of Oncology
MedicineOncologyHematology
2018English

Targeted Therapy in Hepatocellular Carcinoma

International Journal of Hepatology
Hepatology
2011English

A Novel BRD4-NUT Fusion in an Undifferentiated Sinonasal Tumor Highlights Alternative Splicing as a Contributing Oncogenic Factor in NUT Midline Carcinoma

Oncogenesis
Cancer ResearchMolecular Biology
2015English

Molecular Targeted Therapy of Hepatocellular Carcinoma

Journal of Cancer Therapy
2013English

Targeted Therapy for Renal Cell Carcinoma

2011English

Outcomes of Patients With Metastatic Renal Cell Carcinoma Treated With Targeted Therapy After Immuno-Oncology Checkpoint Inhibitors

European urology oncology
OncologyRadiologyUrologyNuclear MedicineImagingSurgery
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy